These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 13898854)

  • 1. [Urinary determination of serotonin in allergic patients. Clinical and biological effects of an antagonist, UML 491 (Deseril Sandoz)].
    GIRARD JP
    Helv Med Acta; 1961 Sep; 28():476-81. PubMed ID: 13898854
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of antiepileptic properties of a lysergic-acid-derivative-UML 491-serotonin antagonist; preliminary report.
    SICUTERI F
    Med Exp Int J Exp Med; 1960; 2():36-9. PubMed ID: 14446407
    [No Abstract]   [Full Text] [Related]  

  • 3. LYSERGIC ACID DIETHYL AMIDE (LSD-25): XXXVII. ANTISEROTONIN ACTION OF LYSERGIC ACID DERIVATIVES IN ALLERGY AND NEUROPSYCHIATRY.
    ABRAMSON HA
    J Asthma Res; 1965 Mar; 2(3):257-62. PubMed ID: 14285481
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of a serotonin antagonist (UML 491) in carcinoid disease.
    PEART WS; ROBERTSON JI
    Lancet; 1961 Nov; 2(7213):1172-4. PubMed ID: 14484792
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of serotonin, of one of its inhibitors (UML 491) and of glucagon on experimental osteolathyrism in the rat].
    FRANCHIMONT P; LEFEBVRE P; VAN CAUWENBERGE H
    C R Seances Soc Biol Fil; 1961; 155():427-31. PubMed ID: 24545609
    [No Abstract]   [Full Text] [Related]  

  • 6. [Action of serotonin (5-HT) and of one of its inhibitors, UML 491, on the development of granulomatous reactions in the rat].
    FRANCHIMONT P; VAN CAUWENBERGE H; LECOMTE J
    C R Seances Soc Biol Fil; 1961; 155():432-5. PubMed ID: 24545610
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).
    FRIEDMAN AP; LOSIN S
    Arch Neurol; 1961 Mar; 4():241-5. PubMed ID: 13701987
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical observations with 1-methyl-lysergic acid butanolamide (UML-491) in vascular headache.
    FRIEDMAN AP
    Angiology; 1960 Aug; 11():364-6. PubMed ID: 13825096
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of the treatment of headache with Deseril].
    BRZECKI A
    Pol Tyg Lek; 1962 Mar; 17():440-2. PubMed ID: 13874157
    [No Abstract]   [Full Text] [Related]  

  • 10. Vasodilating headache: a suggested classification and results of prophylactic treatment with UML 491 (methysergide).
    ROOKE ED; RUSHTON JG; PETERS GA
    Proc Staff Meet Mayo Clin; 1962 Aug; 37():433-43. PubMed ID: 14493709
    [No Abstract]   [Full Text] [Related]  

  • 11. The serotonin antagonist 1-methyl-D-lysergic acid butanolamine (UML-491) or methysergide ('Deseril'), its pharmacodynamics and effects on 'migraine type' vascular headaches.
    LEIGH WE
    S Afr Med J; 1963 Jun; 37():631-7. PubMed ID: 13929429
    [No Abstract]   [Full Text] [Related]  

  • 12. [EFFECT OF LYSENYL, DESERIL AND OTHER SEROTONIN ANTAGONISTS ON BIOCHEMICAL SYSTEMS].
    RYSANEK K; VITEK V
    Act Nerv Super (Praha); 1963 May; 5():210-1. PubMed ID: 14070658
    [No Abstract]   [Full Text] [Related]  

  • 13. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of autistic schizophrenic children with LSD-25 and UML-491.
    BENDER L; GOLDSCHMIDT L; SANKAR DV
    Recent Adv Biol Psychiatry; 1961; 4():170-9. PubMed ID: 13867084
    [No Abstract]   [Full Text] [Related]  

  • 15. Carcinoid syndrome: alleviation of diarrhoea and flushing with "Deseril" and Ro 5-1025.
    DUBACH UC; GSELL OR
    Br Med J; 1962 May; 1(5289):1390-1. PubMed ID: 13888007
    [No Abstract]   [Full Text] [Related]  

  • 16. THE PROPHYLACTIC EFFECT OF 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE (METHYSERGIDE) IN THE TREATMENT OF VASCULAR HEADACHE. A CLINICAL STUDY.
    CROWTHER DL
    Med Exp Int J Exp Med; 1964; 10():137-43. PubMed ID: 14129849
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental studies with the butanolamide and propanolamide of 1-methyl-lysergic acid.
    GELFAND MD; WEST GB
    Int Arch Allergy Appl Immunol; 1961; 18():286-91. PubMed ID: 13704268
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical and rheographic considerations on a new antiserotonin derivative (UML-491) with preventive action in hemicrania].
    REBUCCI GG; COCCAGNA G
    Riv Neurol; 1962; 32():574-85. PubMed ID: 13973457
    [No Abstract]   [Full Text] [Related]  

  • 19. [Substances of urinary elimination causing allergic reactions].
    THIERS H
    Bull Soc Fr Dermatol Syphiligr; 1961; 68():405-8. PubMed ID: 13920672
    [No Abstract]   [Full Text] [Related]  

  • 20. COMPARATIVE STUDY OF ANTISEROTONIN EFFECTS OF LYSENYL AND DESERIL.
    RYSANEK K; VITEK V
    Gastroenterologia; 1964; 102():1-10. PubMed ID: 14187206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.